Similarly, the absence of estrogen receptor (ER) in breast cancer indicates resistance to hormonal therapy, but only 50–75 % of ER positive tumors respond to various hormone manipulations [4, 5]. This evidence concerns the gene ESR1 and breast carcinoma.